These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25995221)

  • 1. Aminomethyl spectinomycins as therapeutics for drug-resistant respiratory tract and sexually transmitted bacterial infections.
    Bruhn DF; Waidyarachchi SL; Madhura DB; Shcherbakov D; Zheng Z; Liu J; Abdelrahman YM; Singh AP; Duscha S; Rathi C; Lee RB; Belland RJ; Meibohm B; Rosch JW; Böttger EC; Lee RE
    Sci Transl Med; 2015 May; 7(288):288ra75. PubMed ID: 25995221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.
    Butler MM; Waidyarachchi SL; Connolly KL; Jerse AE; Chai W; Lee RE; Kohlhoff SA; Shinabarger DL; Bowlin TL
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens.
    Scarff JM; Waidyarachchi SL; Meyer CJ; Lane DJ; Chai W; Lemmon MM; Liu J; Butler MM; Bowlin TL; Lee RE; Panchal RG
    J Antibiot (Tokyo); 2019 Sep; 72(9):693-701. PubMed ID: 31164713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antibacterial action, and ribosome inhibition of deoxyspectinomycins.
    Dharuman S; Wilt LA; Liu J; Reeve SM; Thompson CW; Elmore JM; Shcherbakov D; Lee RB; Böttger EC; Lee RE
    J Antibiot (Tokyo); 2021 Jun; 74(6):381-396. PubMed ID: 33504919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
    Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
    Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
    Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
    Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Aminomethyl Spectinomycins against Complex Upper Respiratory Tract Bacterial Infections.
    Iverson A; Meyer CJ; Vogel P; Waidyarachchi S; Das N; Bruhn DF; Poole A; Butler MM; Bowlin TL; Lee RE; Rosch JW
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telithromycin: a ketolide antibiotic for treatment of respiratory tract infections.
    Lonks JR; Goldmann DA
    Clin Infect Dis; 2005 Jun; 40(11):1657-64. PubMed ID: 15889365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of novel C12 ethyl ketolides.
    Burger MT; Hiebert C; Seid M; Chu DT; Barker L; Langhorne M; Shawar R; Kidney J; Desai MC; Plattner JJ
    Bioorg Med Chem; 2006 Aug; 14(16):5592-604. PubMed ID: 16697203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibacterial agents (2007)].
    Goto H; Iwasaki M
    Jpn J Antibiot; 2015 Feb; 68(1):1-18. PubMed ID: 25980050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
    Pavlović D; Mutak S
    Bioorg Med Chem; 2016 Mar; 24(6):1255-67. PubMed ID: 26860929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010.
    Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H
    Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens.
    Homma T; Fujimura T; Maki H; Yamano Y; Shimada J; Kuwahara S
    J Antimicrob Chemother; 2010 Jul; 65(7):1433-40. PubMed ID: 20472695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.